25 XP   0   0   10

ExpreS2ion Biotech Holding AB
Buy, Hold or Sell?

Let's analyse ExpreS2ion Biotech Holding AB together

PenkeI guess you are interested in ExpreS2ion Biotech Holding AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ExpreS2ion Biotech Holding AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about ExpreS2ion Biotech Holding AB

I send you an email if I find something interesting about ExpreS2ion Biotech Holding AB.

Quick analysis of ExpreS2ion Biotech Holding AB (30 sec.)










What can you expect buying and holding a share of ExpreS2ion Biotech Holding AB? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr1.02
Expected worth in 1 year
kr0.03
How sure are you?
38.7%

+ What do you gain per year?

Total Gains per Share
kr-0.99
Return On Investment
-36.0%

For what price can you sell your share?

Current Price per Share
kr2.75
Expected price per share
kr1.75 - kr3.595
How sure are you?
50%

1. Valuation of ExpreS2ion Biotech Holding AB (5 min.)




Live pricePrice per Share (EOD)

kr2.75

2. Growth of ExpreS2ion Biotech Holding AB (5 min.)




Is ExpreS2ion Biotech Holding AB growing?

Current yearPrevious yearGrowGrow %
How rich?$4.7m$12.7m-$5.5m-78.4%

How much money is ExpreS2ion Biotech Holding AB making?

Current yearPrevious yearGrowGrow %
Making money-$2.1m-$2.7m$516.7k23.6%
Net Profit Margin-1,022.5%-2,851.3%--

How much money comes from the company's main activities?

3. Financial Health of ExpreS2ion Biotech Holding AB (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#762 / 1019

Most Revenue
#624 / 1019

Most Profit
#310 / 1019

Most Efficient
#814 / 1019

What can you expect buying and holding a share of ExpreS2ion Biotech Holding AB? (5 min.)

Welcome investor! ExpreS2ion Biotech Holding AB's management wants to use your money to grow the business. In return you get a share of ExpreS2ion Biotech Holding AB.

What can you expect buying and holding a share of ExpreS2ion Biotech Holding AB?

First you should know what it really means to hold a share of ExpreS2ion Biotech Holding AB. And how you can make/lose money.

Speculation

The Price per Share of ExpreS2ion Biotech Holding AB is kr2.75. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ExpreS2ion Biotech Holding AB.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ExpreS2ion Biotech Holding AB, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr1.02. Based on the TTM, the Book Value Change Per Share is kr-0.25 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.18 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ExpreS2ion Biotech Holding AB.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.03-1.2%-0.04-1.6%-0.05-1.9%-0.03-1.0%-0.02-0.7%
Usd Book Value Change Per Share-0.05-1.8%-0.02-0.8%0.020.6%0.000.1%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-1.8%-0.02-0.8%0.020.6%0.000.1%0.000.1%
Usd Price Per Share0.19-0.29-1.26-1.44-1.16-
Price to Earnings Ratio-1.52--1.64--7.65--23.96--26.23-
Price-to-Total Gains Ratio-3.92--2.39--2.51-22.10-5.99-
Price to Book Ratio2.07-2.09-5.46-70.11-56.38-
Price-to-Total Gains Ratio-3.92--2.39--2.51-22.10-5.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.25135
Number of shares3978
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.00
Usd Total Gains Per Share-0.020.00
Gains per Quarter (3978 shares)-90.0215.60
Gains per Year (3978 shares)-360.1062.41
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-360-37006252
20-720-7300125114
30-1080-10900187176
40-1440-14500250238
50-1800-18100312300
60-2161-21700374362
70-2521-25300437424
80-2881-28900499486
90-3241-32500562548
100-3601-36100624610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.031.00.00.0%0.031.00.00.0%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%9.011.00.045.0%12.019.00.038.7%12.019.00.038.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share1.03.00.025.0%5.07.00.041.7%9.011.00.045.0%12.019.00.038.7%12.019.00.038.7%

Fundamentals of ExpreS2ion Biotech Holding AB

About ExpreS2ion Biotech Holding AB

ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops and produces complex proteins for vaccines and diagnostics in Denmark. The company develops capsid virus-like particle COVID-19 vaccine, which is in Phase III clinical trial. It also develops influenza, breast cancer, and malaria vaccines. In addition, the company licenses its ExpreS2 platform to research institutes and pharmaceutical companies. Further, it sells ExpreS2 test kits and reagents for application as research tools or diagnostics. It has a collaboration agreement with Evaxion Biotech A/S for the development of a novel cytomegalovirus (CMV) vaccine candidate. The company operates an online store. ExpreS2ion Biotech Holding AB (publ) was incorporated in 2015 is based in Helsingborg, Sweden.

Fundamental data was last updated by Penke on 2024-03-30 21:56:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of ExpreS2ion Biotech Holding AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit ExpreS2ion Biotech Holding AB earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare ExpreS2ion Biotech Holding AB to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,022.5%+1,022.5%
TTM-1,022.5%YOY-2,851.3%+1,828.8%
TTM-1,022.5%5Y-885.8%-136.7%
5Y-885.8%10Y-631.5%-254.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--197.2%+197.2%
TTM-1,022.5%-210.4%-812.1%
YOY-2,851.3%-279.3%-2,572.0%
5Y-885.8%-436.8%-449.0%
10Y-631.5%-599.3%-32.2%
1.1.2. Return on Assets

Shows how efficient ExpreS2ion Biotech Holding AB is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ExpreS2ion Biotech Holding AB to the Biotechnology industry mean.
  • -24.0% Return on Assets means that ExpreS2ion Biotech Holding AB generated kr-0.24 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is -24.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -24.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-24.0%TTM-24.2%+0.2%
TTM-24.2%YOY-19.2%-5.0%
TTM-24.2%5Y-17.7%-6.5%
5Y-17.7%10Y-22.7%+5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-24.0%-13.6%-10.4%
TTM-24.2%-12.9%-11.3%
YOY-19.2%-11.9%-7.3%
5Y-17.7%-14.2%-3.5%
10Y-22.7%-16.2%-6.5%
1.1.3. Return on Equity

Shows how efficient ExpreS2ion Biotech Holding AB is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ExpreS2ion Biotech Holding AB to the Biotechnology industry mean.
  • -22.2% Return on Equity means ExpreS2ion Biotech Holding AB generated kr-0.22 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is -22.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.2%TTM-28.1%+5.9%
TTM-28.1%YOY-23.2%-4.9%
TTM-28.1%5Y-66.1%+38.0%
5Y-66.1%10Y-52.2%-13.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.2%-17.0%-5.2%
TTM-28.1%-16.1%-12.0%
YOY-23.2%-15.4%-7.8%
5Y-66.1%-20.0%-46.1%
10Y-52.2%-21.1%-31.1%

1.2. Operating Efficiency of ExpreS2ion Biotech Holding AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient ExpreS2ion Biotech Holding AB is operating .

  • Measures how much profit ExpreS2ion Biotech Holding AB makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ExpreS2ion Biotech Holding AB to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,105.6%+1,105.6%
TTM-1,105.6%YOY-3,070.9%+1,965.3%
TTM-1,105.6%5Y-956.6%-149.0%
5Y-956.6%10Y-683.6%-272.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM-1,105.6%-224.4%-881.2%
YOY-3,070.9%-288.4%-2,782.5%
5Y-956.6%-475.2%-481.4%
10Y-683.6%-624.7%-58.9%
1.2.2. Operating Ratio

Measures how efficient ExpreS2ion Biotech Holding AB is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM11.806-11.806
TTM11.806YOY31.709-19.903
TTM11.8065Y10.478+1.328
5Y10.47810Y7.743+2.735
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.997-2.997
TTM11.8063.247+8.559
YOY31.7093.766+27.943
5Y10.4785.675+4.803
10Y7.7437.857-0.114

1.3. Liquidity of ExpreS2ion Biotech Holding AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if ExpreS2ion Biotech Holding AB is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.00 means the company has kr0.00 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.731-4.731
TTM4.731YOY14.182-9.451
TTM4.7315Y7.748-3.017
5Y7.74810Y6.357+1.391
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.930-3.930
TTM4.7314.251+0.480
YOY14.1825.436+8.746
5Y7.7486.045+1.703
10Y6.3576.363-0.006
1.3.2. Quick Ratio

Measures if ExpreS2ion Biotech Holding AB is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ExpreS2ion Biotech Holding AB to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off kr0.00 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.650-4.650
TTM4.650YOY17.941-13.291
TTM4.6505Y9.003-4.353
5Y9.00310Y6.556+2.447
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.629-3.629
TTM4.6504.065+0.585
YOY17.9415.397+12.544
5Y9.0035.993+3.010
10Y6.5566.277+0.279

1.4. Solvency of ExpreS2ion Biotech Holding AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of ExpreS2ion Biotech Holding AB assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ExpreS2ion Biotech Holding AB to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.29 means that ExpreS2ion Biotech Holding AB assets are financed with 29.4% credit (debt) and the remaining percentage (100% - 29.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is 0.294. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.217. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.294TTM0.217+0.077
TTM0.217YOY0.128+0.089
TTM0.2175Y0.380-0.163
5Y0.38010Y0.466-0.086
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2940.332-0.038
TTM0.2170.334-0.117
YOY0.1280.268-0.140
5Y0.3800.366+0.014
10Y0.4660.390+0.076
1.4.2. Debt to Equity Ratio

Measures if ExpreS2ion Biotech Holding AB is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ExpreS2ion Biotech Holding AB to the Biotechnology industry mean.
  • A Debt to Equity ratio of 27.3% means that company has kr0.27 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is 0.273. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.249. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.273TTM0.249+0.024
TTM0.249YOY0.156+0.093
TTM0.2495Y3.774-3.525
5Y3.77410Y2.749+1.025
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2730.381-0.108
TTM0.2490.390-0.141
YOY0.1560.334-0.178
5Y3.7740.434+3.340
10Y2.7490.466+2.283

2. Market Valuation of ExpreS2ion Biotech Holding AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings ExpreS2ion Biotech Holding AB generates.

  • Above 15 is considered overpriced but always compare ExpreS2ion Biotech Holding AB to the Biotechnology industry mean.
  • A PE ratio of -1.52 means the investor is paying kr-1.52 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ExpreS2ion Biotech Holding AB:

  • The EOD is -1.984. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.522. Based on the earnings, the company is expensive. -2
  • The TTM is -1.641. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.984MRQ-1.522-0.462
MRQ-1.522TTM-1.641+0.120
TTM-1.641YOY-7.649+6.007
TTM-1.6415Y-23.959+22.317
5Y-23.95910Y-26.226+2.268
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.984-2.315+0.331
MRQ-1.522-2.560+1.038
TTM-1.641-2.664+1.023
YOY-7.649-4.122-3.527
5Y-23.959-6.258-17.701
10Y-26.226-6.108-20.118
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ExpreS2ion Biotech Holding AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1.135+1.135
TTM-1.135YOY-8.084+6.949
TTM-1.1355Y-24.457+23.322
5Y-24.45710Y-28.621+4.164
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.251+3.251
TTM-1.135-3.545+2.410
YOY-8.084-5.595-2.489
5Y-24.457-8.315-16.142
10Y-28.621-8.708-19.913
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of ExpreS2ion Biotech Holding AB is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.07 means the investor is paying kr2.07 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of ExpreS2ion Biotech Holding AB:

  • The EOD is 2.697. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.069. Based on the equity, the company is underpriced. +1
  • The TTM is 2.085. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.697MRQ2.069+0.628
MRQ2.069TTM2.085-0.016
TTM2.085YOY5.462-3.377
TTM2.0855Y70.106-68.020
5Y70.10610Y56.383+13.722
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.6971.905+0.792
MRQ2.0692.111-0.042
TTM2.0852.095-0.010
YOY5.4622.836+2.626
5Y70.1063.443+66.663
10Y56.3833.794+52.589
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of ExpreS2ion Biotech Holding AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.538-0.248-54%0.176-405%0.043-1354%0.033-1736%
Book Value Per Share--1.0201.521-33%2.712-62%1.370-26%0.962+6%
Current Ratio---4.731-100%14.182-100%7.748-100%6.357-100%
Debt To Asset Ratio--0.2940.217+35%0.128+129%0.380-23%0.466-37%
Debt To Equity Ratio--0.2730.249+10%0.156+75%3.774-93%2.749-90%
Dividend Per Share----0%-0%-0%-0%
Eps---0.347-0.467+35%-0.577+66%-0.292-16%-0.215-38%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.073-7%
Market Cap141363750.000+23%108464550.000162221328.750-33%710866893.750-85%911415628.000-88%716605493.871-85%
Net Profit Margin----10.2250%-28.5130%-8.8580%-6.3150%
Operating Margin----11.0560%-30.7090%-9.5660%-6.8360%
Operating Ratio---11.806-100%31.709-100%10.478-100%7.743-100%
Pb Ratio2.697+23%2.0692.085-1%5.462-62%70.106-97%56.383-96%
Pe Ratio-1.984-30%-1.522-1.641+8%-7.649+403%-23.959+1474%-26.226+1623%
Price Per Share2.750+23%2.1103.156-33%13.829-85%15.720-87%12.644-83%
Price To Free Cash Flow Ratio----1.1350%-8.0840%-24.4570%-28.6210%
Price To Total Gains Ratio-5.110-30%-3.921-2.391-39%-2.514-36%22.097-118%5.991-165%
Quick Ratio---4.650-100%17.941-100%9.003-100%6.556-100%
Return On Assets---0.240-0.242+1%-0.192-20%-0.177-26%-0.227-5%
Return On Equity---0.222-0.281+26%-0.232+4%-0.661+197%-0.522+135%
Total Gains Per Share---0.538-0.248-54%0.176-405%0.043-1354%0.033-1736%
Usd Book Value--4790822.4007144212.450-33%12743742.050-62%6769554.710-29%4738067.844+1%
Usd Book Value Change Per Share---0.049-0.023-54%0.016-405%0.004-1354%0.003-1736%
Usd Book Value Per Share--0.0930.139-33%0.248-62%0.125-26%0.088+6%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.032-0.043+35%-0.053+66%-0.027-16%-0.020-38%
Usd Free Cash Flow----2008674.9500%-2284908.6000%-1218796.1500%-851190.5100%
Usd Market Cap12920646.750+23%9913659.87014827029.448-33%64973234.089-85%83303388.399-88%65497742.140-85%
Usd Price Per Share0.251+23%0.1930.288-33%1.264-85%1.437-87%1.156-83%
Usd Profit---1628473.800-2193348.650+35%-2710124.250+66%-1402697.520-14%-1028742.381-37%
Usd Revenue---135751.850-100%116215.100-100%193534.930-100%204907.006-100%
Usd Total Gains Per Share---0.049-0.023-54%0.016-405%0.004-1354%0.003-1736%
 EOD+4 -3MRQTTM+8 -17YOY+7 -185Y+6 -1910Y+9 -17

3.2. Fundamental Score

Let's check the fundamental score of ExpreS2ion Biotech Holding AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.984
Price to Book Ratio (EOD)Between0-12.697
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than10.294
Debt to Equity Ratio (MRQ)Less than10.273
Return on Equity (MRQ)Greater than0.15-0.222
Return on Assets (MRQ)Greater than0.05-0.240
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of ExpreS2ion Biotech Holding AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.168
Ma 20Greater thanMa 502.367
Ma 50Greater thanMa 1002.706
Ma 100Greater thanMa 2002.766
OpenGreater thanClose2.800
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
EBIT  -53,08223,111-29,971-3,264-33,23511,073-22,16224,4462,284
EBITDA  -52,93223,290-29,642-3,160-32,80211,070-21,73225,5133,781
Operating Income  -53,08223,111-29,971-3,264-33,23511,073-22,16224,4462,284



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets74,255
Total Liabilities0
Total Stockholder Equity0
 As reported
Total Liabilities 0
Total Stockholder Equity+ 0
Total Assets = 74,255

Assets

Total Assets74,255
Total Current Assets0
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 57,597
Other Current Assets -57,597
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Cash and Short Term Investments 57,597
Common Stock Shares Outstanding 51,405
Net Debt -57,597



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-03-31
> Total Assets 
4,125
27,816
24,615
22,451
19,903
20,470
17,235
34,022
29,769
24,945
20,954
24,177
21,258
18,547
18,707
22,100
28,291
42,916
118,858
98,083
128,398
159,428
151,956
140,035
188,480
170,498
137,363
103,125
115,909
101,920
74,255
74,255101,920115,909103,125137,363170,498188,480140,035151,956159,428128,39898,083118,85842,91628,29122,10018,70718,54721,25824,17720,95424,94529,76934,02217,23520,47019,90322,45124,61527,8164,125
   > Total Current Assets 
3,793
14,893
11,793
10,181
8,043
9,112
6,054
22,960
18,691
14,549
10,832
14,427
11,552
9,317
10,137
13,487
20,550
35,735
112,463
92,106
122,527
153,628
146,464
134,718
182,982
165,109
131,943
96,582
108,748
95,372
0
095,372108,74896,582131,943165,109182,982134,718146,464153,628122,52792,106112,46335,73520,55013,48710,1379,31711,55214,42710,83214,54918,69122,9606,0549,1128,04310,18111,79314,8933,793
       Cash And Cash Equivalents 
480
10,034
6,258
2,460
1,464
3,972
1,508
17,775
12,219
9,758
6,255
10,139
5,013
2,628
5,418
6,194
12,764
30,399
106,832
82,807
108,289
141,998
37,111
39,563
167,719
149,561
110,974
71,972
88,302
77,182
57,597
57,59777,18288,30271,972110,974149,561167,71939,56337,111141,998108,28982,807106,83230,39912,7646,1945,4182,6285,01310,1396,2559,75812,21917,7751,5083,9721,4642,4606,25810,034480
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
101,769
85,115
0
0
0
-1,709
-1,788
-1,740
0
0-1,740-1,788-1,70900085,115101,7690000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
402
2,367
1,980
4,348
5,572
6,675
3,506
5,104
8,481
13,576
11,047
7,105
8,282
7,935
9,299
826
24,610
20,446
18,190
0
018,19020,44624,6108269,2997,9358,2827,10511,04713,5768,4815,1043,5066,6755,5724,3481,9802,36740200000000000
       Other Current Assets 
3,313
4,859
5,535
7,721
6,579
5,140
4,546
5,185
6,472
4,791
4,577
4,288
6,539
6,689
4,719
7,293
7,786
5,336
5,631
9,299
14,238
11,630
7,584
10,040
15,263
15,548
0
22,821
19,037
0
-57,597
-57,597019,03722,821015,54815,26310,0407,58411,63014,2389,2995,6315,3367,7867,2934,7196,6896,5394,2884,5774,7916,4725,1854,5465,1406,5797,7215,5354,8593,313
   > Long-term Assets 
332
12,923
12,822
12,270
11,860
11,358
11,181
11,062
11,078
10,396
10,122
9,750
9,706
9,230
8,570
8,613
7,741
7,181
6,395
5,977
5,871
5,800
5,492
5,317
5,498
5,389
5,420
6,543
7,161
6,548
0
06,5487,1616,5435,4205,3895,4985,3175,4925,8005,8715,9776,3957,1817,7418,6138,5709,2309,7069,75010,12210,39611,07811,06211,18111,35811,86012,27012,82212,923332
       Property Plant Equipment 
113
278
679
616
558
607
632
579
1,007
864
993
887
1,218
1,178
1,186
1,328
1,381
1,230
1,294
1,225
1,419
1,420
1,209
1,037
948
850
910
1,939
2,469
2,102
0
02,1022,4691,9399108509481,0371,2091,4201,4191,2251,2941,2301,3811,3281,1861,1781,2188879938641,007579632607558616679278113
       Goodwill 
0
0
2,403
0
2,148
0
1,900
1,834
1,706
1,536
1,383
1,252
1,125
980
802
693
505
355
194
50
0
0
0
0
0
0
0
0
0
0
0
00000000000501943555056938029801,1251,2521,3831,5361,7061,8341,90002,14802,40300
       Intangible Assets 
0
0
9,461
0
8,834
0
8,241
8,218
7,929
7,439
7,030
6,743
6,478
6,180
5,614
5,548
4,863
4,497
3,907
3,601
3,363
3,240
3,142
3,068
3,056
3,011
2,953
2,869
2,877
2,680
0
02,6802,8772,8692,9533,0113,0563,0683,1423,2403,3633,6013,9074,4974,8635,5485,6146,1806,4786,7437,0307,4397,9298,2188,24108,83409,46100
       Long-term Assets Other 
219
230
279
284
320
398
408
431
436
557
716
868
885
892
968
1,044
992
1,099
1,000
1,101
1,089
1,140
102,887
86,303
1,494
1,528
1,557
1,735
1,815
1,766
0
01,7661,8151,7351,5571,5281,49486,303102,8871,1401,0891,1011,0001,0999921,044968892885868716557436431408398320284279230219
> Total Liabilities 
8,490
10,531
11,735
10,667
10,671
10,732
10,498
12,186
11,323
11,118
12,653
12,800
12,934
13,113
19,786
19,358
24,093
42,153
24,310
12,849
15,340
13,440
11,610
8,707
14,296
21,624
34,036
23,656
15,218
21,839
0
021,83915,21823,65634,03621,62414,2968,70711,61013,44015,34012,84924,31042,15324,09319,35819,78613,11312,93412,80012,65311,11811,32312,18610,49810,73210,67110,66711,73510,5318,490
   > Total Current Liabilities 
8,490
2,330
3,585
2,982
3,254
2,288
2,361
3,724
2,801
3,198
5,044
5,498
4,379
4,896
12,215
11,898
16,703
31,747
18,211
7,201
10,361
8,829
7,461
4,997
10,944
18,655
31,426
20,475
11,806
19,086
0
019,08611,80620,47531,42618,65510,9444,9977,4618,82910,3617,20118,21131,74716,70311,89812,2154,8964,3795,4985,0443,1982,8013,7242,3612,2883,2542,9823,5852,3308,490
       Short-term Debt 
1,163
1,163
0
695
1,051
44
75
68
411
667
924
1,187
635
895
1,493
1,951
1,221
1,630
1,889
1,927
1,966
1,960
1,918
1,863
1,829
1,810
1,763
2,006
2,116
2,085
0
02,0852,1162,0061,7631,8101,8291,8631,9181,9601,9661,9271,8891,6301,2211,9511,4938956351,1879246674116875441,05169501,1631,163
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
1,187
635
895
1,493
1,951
1,221
1,630
1,889
1,927
1,966
1,960
1,918
1,863
1,829
1,810
1,763
2,006
2,116
2,085
0
02,0852,1162,0061,7631,8101,8291,8631,9181,9601,9661,9271,8891,6301,2211,9511,4938956351,18700000000000
       Accounts payable 
553
529
799
450
554
702
470
619
591
851
607
1,029
1,284
777
1,082
1,350
1,401
1,070
2,078
1,773
1,739
1,761
1,685
106
5,789
12,984
12,152
11,813
2,334
3,230
0
03,2302,33411,81312,15212,9845,7891061,6851,7611,7391,7732,0781,0701,4011,3501,0827771,2841,029607851591619470702554450799529553
       Other Current Liabilities 
6,774
638
2,786
1,837
1,649
1,542
1,816
3,037
1,799
1,680
3,513
3,282
2,460
3,224
9,640
8,597
14,081
29,047
14,244
3,501
6,656
5,108
3,858
3,028
3,326
3,861
17,511
6,656
7,356
13,771
0
013,7717,3566,65617,5113,8613,3263,0283,8585,1086,6563,50114,24429,04714,0818,5979,6403,2242,4603,2823,5131,6801,7993,0371,8161,5421,6491,8372,7866386,774
   > Long-term Liabilities 
0
8,201
8,150
7,685
7,417
8,444
8,137
8,462
8,522
7,920
7,609
7,302
8,555
8,217
7,571
7,460
7,390
10,406
6,099
5,648
4,979
4,611
4,149
3,710
3,352
2,969
2,610
3,181
3,412
2,753
0
02,7533,4123,1812,6102,9693,3523,7104,1494,6114,9795,6486,09910,4067,3907,4607,5718,2178,5557,3027,6097,9208,5228,4628,1378,4447,4177,6858,1508,2010
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,454
5,272
4,887
4,270
3,920
3,477
3,077
2,722
2,348
0
0
0
0
0
000002,3482,7223,0773,4773,9204,2704,8875,2729,45400000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
8,555
8,217
7,571
7,460
1,032
952
5,608
5,648
4,979
4,611
3,957
3,709
3,352
2,969
2,610
0
0
0
0
00002,6102,9693,3523,7093,9574,6114,9795,6485,6089521,0327,4607,5718,2178,555000000000000
> Total Stockholder Equity
-4,366
17,285
12,880
11,784
9,232
9,738
6,737
21,836
18,446
13,827
8,301
11,377
8,324
5,434
-1,079
2,742
4,198
763
94,548
85,234
113,058
145,988
140,346
131,328
174,184
148,874
103,327
79,469
100,691
80,081
0
080,081100,69179,469103,327148,874174,184131,328140,346145,988113,05885,23494,5487634,1982,742-1,0795,4348,32411,3778,30113,82718,44621,8366,7379,7389,23211,78412,88017,285-4,366
   Common Stock
641
970
970
970
970
1,067
1,067
1,334
1,334
1,334
1,334
1,512
1,511
1,512
1,512
1,689
1,789
1,818
3,067
3,068
3,265
3,461
3,461
3,461
4,111
4,179
4,179
4,179
5,472
5,712
0
05,7125,4724,1794,1794,1794,1113,4613,4613,4613,2653,0683,0671,8181,7891,6891,5121,5121,5111,5121,3341,3341,3341,3341,0671,067970970970970641
   Retained Earnings 00000-157,703-125,196-98,790-129,358-114,911-20,652-11,323-32,683-66,259-61,255-56,758-51,5630000000000000-5,007
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48,972
57,811
63,664
65,204
124,223
93,489
130,445
257,438
266,243
226,657
295,269
302,398
0
0
0
0
0
00000302,398295,269226,657266,243257,438130,44593,489124,22365,20463,66457,81148,97200000000000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 
0
16,315
11,910
10,814
8,262
8,671
5,670
20,502
17,112
12,493
6,967
9,865
6,813
3,922
-2,591
1,053
2,409
-1,055
91,481
82,166
109,793
142,527
136,885
127,867
170,073
144,695
99,148
222,496
272,462
567,139
0
0567,139272,462222,49699,148144,695170,073127,867136,885142,527109,79382,16691,481-1,0552,4091,053-2,5913,9226,8139,8656,96712,49317,11220,5025,6708,6718,26210,81411,91016,3150



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue6,913
Cost of Revenue-4,449
Gross Profit2,4642,464
 
Operating Income (+$)
Gross Profit2,464
Operating Expense-8,799
Operating Income8,799-6,335
 
Operating Expense (+$)
Research Development80,022
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense8,79980,022
 
Net Interest Income (+$)
Interest Income398
Interest Expense-476
Other Finance Cost-0
Net Interest Income-78
 
Pretax Income (+$)
Operating Income8,799
Net Interest Income-78
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-104,555122,153
EBIT - interestExpense = 8,323
-104,555
-95,513
Interest Expense476
Earnings Before Interest and Taxes (EBIT)8,799-104,079
Earnings Before Interest and Taxes (EBITDA)17,365
 
After tax Income (+$)
Income Before Tax-104,555
Tax Provision--11,823
Net Income From Continuing Ops-126,705-92,732
Net Income-95,989
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses8,799
Total Other Income/Expenses Net-113,35478
 

Technical Analysis of ExpreS2ion Biotech Holding AB
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ExpreS2ion Biotech Holding AB. The general trend of ExpreS2ion Biotech Holding AB is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ExpreS2ion Biotech Holding AB's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ExpreS2ion Biotech Holding AB.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.92 < 3.595 < 3.595.

The bearish price targets are: 2.7 > 2 > 1.75.

Tweet this
ExpreS2ion Biotech Holding AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ExpreS2ion Biotech Holding AB. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ExpreS2ion Biotech Holding AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ExpreS2ion Biotech Holding AB. The current macd is -0.05960721.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ExpreS2ion Biotech Holding AB price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for ExpreS2ion Biotech Holding AB. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the ExpreS2ion Biotech Holding AB price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ExpreS2ion Biotech Holding AB Daily Moving Average Convergence/Divergence (MACD) ChartExpreS2ion Biotech Holding AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ExpreS2ion Biotech Holding AB. The current adx is 20.22.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy ExpreS2ion Biotech Holding AB shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
ExpreS2ion Biotech Holding AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ExpreS2ion Biotech Holding AB. The current sar is 2.0159.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
ExpreS2ion Biotech Holding AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ExpreS2ion Biotech Holding AB. The current rsi is 61.17. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
ExpreS2ion Biotech Holding AB Daily Relative Strength Index (RSI) ChartExpreS2ion Biotech Holding AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ExpreS2ion Biotech Holding AB. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ExpreS2ion Biotech Holding AB price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
ExpreS2ion Biotech Holding AB Daily Stochastic Oscillator ChartExpreS2ion Biotech Holding AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ExpreS2ion Biotech Holding AB. The current cci is 251.17.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
ExpreS2ion Biotech Holding AB Daily Commodity Channel Index (CCI) ChartExpreS2ion Biotech Holding AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ExpreS2ion Biotech Holding AB. The current cmo is 38.60.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
ExpreS2ion Biotech Holding AB Daily Chande Momentum Oscillator (CMO) ChartExpreS2ion Biotech Holding AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ExpreS2ion Biotech Holding AB. The current willr is -36.70886076.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that ExpreS2ion Biotech Holding AB is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ExpreS2ion Biotech Holding AB Daily Williams %R ChartExpreS2ion Biotech Holding AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ExpreS2ion Biotech Holding AB.

ExpreS2ion Biotech Holding AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ExpreS2ion Biotech Holding AB. The current atr is 0.27157042.

ExpreS2ion Biotech Holding AB Daily Average True Range (ATR) ChartExpreS2ion Biotech Holding AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ExpreS2ion Biotech Holding AB. The current obv is 25,438,861.

ExpreS2ion Biotech Holding AB Daily On-Balance Volume (OBV) ChartExpreS2ion Biotech Holding AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ExpreS2ion Biotech Holding AB. The current mfi is 64.12.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
ExpreS2ion Biotech Holding AB Daily Money Flow Index (MFI) ChartExpreS2ion Biotech Holding AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ExpreS2ion Biotech Holding AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-10BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

ExpreS2ion Biotech Holding AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ExpreS2ion Biotech Holding AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.168
Ma 20Greater thanMa 502.367
Ma 50Greater thanMa 1002.706
Ma 100Greater thanMa 2002.766
OpenGreater thanClose2.800
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of ExpreS2ion Biotech Holding AB with someone you think should read this too:
  • Are you bullish or bearish on ExpreS2ion Biotech Holding AB? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ExpreS2ion Biotech Holding AB? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ExpreS2ion Biotech Holding AB

I send you an email if I find something interesting about ExpreS2ion Biotech Holding AB.


Comments

How you think about this?

Leave a comment

Stay informed about ExpreS2ion Biotech Holding AB.

Receive notifications about ExpreS2ion Biotech Holding AB in your mailbox!